Characterisation of Ilomastat for Prolonged Ocular Drug Release

We are developing tablet dosage forms for implantation directly into the subconjunctival space of the eye. The matrix metalloproteinase inhibitor, ilomastat, has previously been shown to be efficacious at suppressing scarring following glaucoma filtration surgery (GFS). We report on the physical cha...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Parkinson, Gary, Gaisford, Simon, Ru, Qian, Lockwood, Alastair, Khalili, Ashkan, Sheridan, Rose, Khaw, Peng T., Brocchini, Steve, Fadda, Hala M.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2012
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513442/
https://ncbi.nlm.nih.gov/pubmed/22903888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-012-9832-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares